超声引导下连续膝神经射频治疗关节置换术后持续性膝关节疼痛的评估
单中心回顾性研究纳入23例全膝关节置换术后慢性膝痛且病因不明、常规治疗无效的患者,行超声引导下诊断性神经阻滞后连续膝神经射频治疗。1个月时平均NRS评分从8.0±1.4降至6.0±3.4(p=0.01),47.8%患者疼痛减轻≥2分,34.8%疼痛减轻≥50%;6个月时平均NRS评分为6.6±3.0,与基线和1个月相比无统计学显著差异;神经阻滞测试结果与射频疗效无显著相关性,无重大并发症。
要点
- 1个月时47.8%患者疼痛减轻≥2分,34.8%疼痛减轻≥50%。
- 6个月平均NRS评分6.6±3.0,与基线及1个月相比无统计学显著差异。
核心结论
- 连续超声引导下膝神经射频似乎是治疗病因不明的慢性关节置换术后膝痛的一种安全有效的微创选择。
研究设计与样本
- 单中心回顾性研究,纳入2021年12月至2024年4月间23例全膝关节置换术后慢性膝痛、无明确病因且常规治疗无效的患者,行超声引导下诊断性神经阻滞后连续膝神经射频,靶向膝上内侧、膝上外侧和膝下内侧神经。
诊断标准与关键数值
- 采用数字评分量表(NRS)评估疼痛,在基线、1个月和6个月进行比较。
- 1个月时平均NRS评分从基线8.0±1.4降至6.0±3.4(p=0.01)。
- 1个月时47.8%患者达到临床显著疼痛减轻(≥2分下降),34.8%患者达到≥50%减轻。
- 6个月时平均NRS评分为6.6±3.0,与基线及1个月NRS评分相比无统计学显著差异。
- 麻醉神经阻滞测试结果与治疗疗效之间无显著相关性。
临床应用与阅片要点
- 对于全膝关节置换术后慢性膝痛且无明确病因、常规治疗无效的患者,连续超声引导下膝神经射频似乎可提供1个月时的临床显著疼痛缓解并维持至6个月。
- 诊断性神经阻滞测试结果与射频疗效无显著相关性,作者指出预后性神经阻滞与射频结局不相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the efficacy of continuous ultrasound-guided genicular nerve radiofrequency (GNRF) for managing persistent post-arthroplasty knee pain of unknown etiology.
MATERIALS AND METHODS: In this single-center retrospective study, patients presenting with chronic knee pain following total knee arthroplasty, with no identifiable underlying cause and unresponsive to conventional treatments, underwent ultrasound-guided diagnostic nerve blocks followed by continuous GNRF targeting the supero-medial, supero-lateral, and infero-medial genicular nerves. Pain scores using a numeric rating scale (NRS) were assessed and compared at baseline, 1 month, and 6 months. The correlation between anesthetic nerve block test results and treatment efficacy was also analyzed.
RESULTS: Twenty-three patients (mean age 69.9 ± 12.1 [SD], 9 men) were included between December 2021 and April 2024. At 1 month, the mean NRS score decreased from 8.0 ± 1.4 to 6.0 ± 3.4 [SD] (p = 0.01). Clinically significant pain reduction (≥ 2-point decrease) was observed in 47.8% of patients; 34.8% achieved a ≥ 50% reduction. At 6 months, the mean NRS score was 6.6 ± 3.0 [SD], with no statistically significant difference compared to baseline and 1-month NRS scores. No significant correlation was found between nerve block test outcomes and GNRF efficacy. No major complications were reported.
CONCLUSION: Continuous ultrasound-guided GNRF appears to be a safe and effective minimally invasive option for chronic post-arthroplasty knee pain with no known underlying etiology.
KEY POINTS: Question Persistent post-arthroplasty knee pain with no identified underlying etiology is frequent and often difficult to manage with conventional therapies. Findings Ultrasound-guided continuous GNRF provides clinically significant pain relief at 1 month and up to 6 months. Clinical relevance Prognostic nerve blocks did not correlate with radiofrequency outcomes.
引用
- El Khalfi R, Larribeau É, Froidefond P, et al. Assessment of ultrasound-guided continuous genicular nerve radiofrequency for the management of persistent post-arthroplasty knee pain. Eur Radiol. 2025. PMID: 41436644. doi:10.1007/s00330-025-12140-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。